Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
101.74
+0.24 (+0.24%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results
↗
November 04, 2025
Via
Benzinga
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
November 04, 2025
Via
Benzinga
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
November 04, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year...
Via
StockStory
Exact Sciences to Participate in November Investor Conference
November 04, 2025
From
Exact Sciences Corp.
Via
Business Wire
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
Earnings Preview: Exact Sciences
↗
October 31, 2025
Via
Benzinga
Exact Sciences (EXAS) Q3 2025 Earnings Transcript
↗
November 03, 2025
Exact Sciences (EXAS) Q3 2025 Earnings Transcript
Via
The Motley Fool
Topics
Earnings
Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars
November 03, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year...
Via
StockStory
Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat
↗
November 03, 2025
Exact Sciences stock jumped late Monday on strong third-quarter sales, despite continued losses. The company raised its sales guide.
Via
Investor's Business Daily
Topics
Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 03, 2025
Via
Benzinga
Exact Sciences Announces Third Quarter 2025 Results
November 03, 2025
From
Exact Sciences Corp.
Via
Business Wire
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
↗
November 03, 2025
Wall Street opened the week on a mixed note on Monday.
Via
Benzinga
Should You Buy Exact Sciences Stock Before Nov. 3?
↗
November 02, 2025
The company's outlook is improving as its innovative ways continue to pay off.
Via
The Motley Fool
Exact Sciences (EXAS) Reports Q3: Everything You Need To Know Ahead Of Earnings
November 01, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be announcing earnings results this Monday after market hours. Here’s what to expect.
Via
StockStory
3 Unprofitable Stocks with Questionable Fundamentals
October 30, 2025
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Via
StockStory
3 Cash-Producing Stocks We Think Twice About
October 28, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
October 27, 2025
From
Exact Sciences Corp.
Via
Business Wire
11 Analysts Have This To Say About Exact Sciences
↗
October 22, 2025
Via
Benzinga
Immuno-Oncology Stocks Q2 Recap: Benchmarking Exact Sciences (NASDAQ:EXAS)
October 21, 2025
Looking back on immuno-oncology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Exact Sciences (NASDAQ:EXAS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
3 High-Flying Stocks We Steer Clear Of
October 17, 2025
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...
Via
StockStory
Topics
Firearms
Exact Sciences Schedules Third Quarter 2025 Earnings Call
October 08, 2025
From
Exact Sciences Corp.
Via
Business Wire
New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies
October 07, 2025
From
Exact Sciences Corp.
Via
Business Wire
What Analysts Are Saying About Exact Sciences Stock
↗
October 02, 2025
Via
Benzinga
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
October 02, 2025
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...
Via
MarketMinute
Topics
Artificial Intelligence
Derivatives
Exact Sciences (EXAS) Stock Trades Up, Here Is Why
September 25, 2025
Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 2.2% in the afternoon session after the Nancy Gardner Sewell MCED Act advanced in the U.S. House, a development that could...
Via
StockStory
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test
September 22, 2025
From
Exact Sciences Corp.
Via
Business Wire
Peering Into Exact Sciences's Recent Short Interest
↗
September 18, 2025
Via
Benzinga
Demystifying Exact Sciences: Insights From 9 Analyst Reviews
↗
September 11, 2025
Via
Benzinga
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
September 10, 2025
From
Exact Sciences Corp.
Via
Business Wire
Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio?
↗
September 07, 2025
These ten large-cap stocks were top performers last week. Are they a part of your portfolio?
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today